5 Biotechs Drawing Buyout Buzz in 2018 Post author:Sam Post published:January 23, 2018 Post category:BioPharma Here are five possible acquisition targets to keep an eye on. Source: BioSpace You Might Also Like MeiraGTx Earns EMA PRIME Designation for Achromatopsia Gene Therapy Candidate March 1, 2018 Vividion Therapeutics Snags $101M from Celgene March 4, 2018 Senseonics Prices $41 Million Underwritten Offering of Common Stock May 25, 2017
